Refreshed content for Tirzepatideai_activityai-researcherApr 17, 2026
Pulled 2 linked studies for context.
No external link
Summary not yet generated. The Librarian will pick this up on the next daily run (12:00 UTC).
Community effect votes, structured logs, and side-effect summaries.
Effect profile (overview)
Aggregate AI baseline blended with community voting. Hover to inspect effect strengths per category.
Effect scores blend an AI baseline with community votes. Open the full chart to see sliders and vote on each category.
Research log summary heatmap
Compact view of how logs describe shifts in pain, sleep, and performance (−5 to +5). Treat this as qualitative, anonymous signal only.
No community research logs yet. When structured logs are added, this panel will summarize typical shifts in pain, sleep, and performance.
Anonymous side-effect patterns
Rough heatmap of anonymous side-effect and positive-signal tags — a "most-mentioned" snapshot, not safety or efficacy advice.
No anonymous side-effect reports yet. When reports are submitted, this panel will show a simple heatmap of tags like "nausea", "flushing", "improved healing", and more.
Research footprint
Last analyzed Apr 17, 20265
Studies indexed
0
Human
0
Animal
3
AI analyzed
Evidence mix0% human · 0% animal · 0% cellular · 0% review
Highest phase: Preclinical onlyYears covered: 2026
Librarian pulse — latest actionsFull changelog ↓
- Apr 17, 12:04 PMRefreshedRefreshed content for Tirzepatide
- Apr 16, 5:14 PMRefreshedRefreshed content for Tirzepatide
- Apr 16, 5:14 PMRefreshedRefreshed content for Tirzepatide
Research & intelligence feed
Studies, clinical trials, community discussions, and news.
Refreshed content for Tirzepatideai_activityai-researcherApr 16, 2026
Pulled 2 linked studies for context. - **content** added: Body content generated (1192 chars).
No external link
Refreshed content for Tirzepatideai_activityai-researcherApr 16, 2026
Pulled 2 linked studies for context. - **content** added: Body content generated (1120 chars).
No external link
Conduct of the REsponses in Function and Outcomes From RYGB vs. Medication Study (REFORM) Study by Research CoordinatorsClinical TrialClinicalTrials.govApr 16, 2026
Not reported in abstract.
Status: RECRUITING
A Parallel-Group Treatment, Phase 2, Double-Blind Study of Once-Weekly Subcutaneous LY3457263 Compared to Placebo in Participants With Type 2 Diabetes Mellitus on a Stable Dose of Semaglutide or Tirzepatide Who Failed to Achieve HbA1c GoalClinical TrialClinicalTrials.govApr 16, 2026
This study evaluated the efficacy of once-weekly subcutaneous LY3457263 compared to placebo in participants with Type 2 Diabetes Mellitus who were on a stable dose of Semaglutide or Tirzepatide and had not achieved their HbA1c goal. The specific outcomes and numeric findings are not detailed in the abstract. The study is classified as a Phase 2 trial.
Phase: PHASE2Status: RECRUITING
A Two-Part, Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study of ALN-PNP With and Without a GLP1R Agonist in Adults With Homozygous PNPLA3-Related Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Clinical TrialClinicalTrials.govApr 16, 2026
Not reported in abstract.
Phase: PHASE2Status: NOT_YET_RECRUITING
Semantic Scholar search for TirzepatideStudySemanticScholarDec 12, 2025
Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review.StudyPubMedDec 12, 2025
Drugs · 2025
External databases
Helpful external resources for additional structural, pharmacologic, and literature context. These are third-party databases; always cross-check details with primary research.
Community notes
No comments yet. Share research notes, citations, or observations below.
Community research logs (detail)
No community research logs yet. Use the “Contribute data” button above to share an anonymized summary of your experience.
Anonymous side-effect reporting (detail)
This section describes how anonymous side-effect reports are aggregated into the heatmap above. Reports are anonymous and unverified, and should be read alongside primary safety data.
Use the "Report side effects" button to open a focused popup form. Please keep descriptions neutral and avoid medical language; think in terms of "nausea", "flushing", "vivid dreams", etc.
Librarian Changelog
Every time the Librarian touches this peptide — discovering, refreshing, scoring, or verifying — it logs the action here.
22h agoRefreshai-researcher85%
Refreshed content for Tirzepatide
1d agoRefreshai-researcher85%
Refreshed content for Tirzepatide
1d agoRefreshai-researcher85%
Refreshed content for Tirzepatide